Drug Sales Trends for TOPICORT

Annual Sales Revenues and Units Sold for TOPICORT

These sales figures are drawn from a US national survey of drug expenditures

Drug Name	Revenues (USD)	Units	Year
TOPICORT			2021
TOPICORT			2020
TOPICORT			2019
TOPICORT			2018

Market Analysis and Sales Projections for Topical Drugs: A Focus on Topical Corticosteroids like Topirol (Generic for Topical Corticosteroids)

Introduction to Topical Drugs

Topical drugs, including topical corticosteroids, are a crucial segment of the pharmaceutical industry, particularly in the treatment of skin conditions. These medications are applied directly to the skin to provide localized relief from various dermatological issues.

Global Topical Drugs Market Overview

The global topical drugs market is experiencing significant growth, driven by the increasing prevalence of skin conditions and chronic diseases. Here are some key statistics:

• The global topical drugs market was estimated at USD 190.5 billion in 2024 and is projected to grow at a CAGR of 6.0% from 2025 to 2030[4].

Topical Corticosteroids Market

Topical corticosteroids, such as those under the brand or generic names like Topirol, are a subset of topical drugs that play a vital role in treating skin conditions.

Market Size and Growth

• The global Topical Corticosteroids Market was valued at USD 4.85 billion in 2021 and is expected to reach USD 8.19 billion by 2030, growing at a CAGR of 6% during the forecast period[2].

Regional Market Performance

• North America emerged as the largest market for topical corticosteroids in 2021, with a market share of around 38%. This region's growth is attributed to the rising number of product launches, strong healthcare infrastructure, and increasing prevalence of skin diseases[2].

• The Asia Pacific region is expected to grow the fastest during the forecast period, driven by rising healthcare expenditures, higher prevalence of skin disorders, and enhanced awareness of dermatological health[2].

Key Drivers of the Market

Increasing Prevalence of Skin Conditions

• Skin issues such as acne, eczema, and psoriasis affect a significant portion of the global population. For instance, in the U.S., these conditions affect approximately 50 million individuals annually[4].

Advancements in Medical Research

• The expanding body of knowledge within medical research has broadened the potential for expansion of the topical corticosteroids market. New research findings and approvals of semi-solid topical drugs have contributed significantly to market growth[2].

Regulatory Approvals and Product Launches

• The market for topical corticosteroids has been expanding due to the rising number of product launches and approvals by regulatory agencies. This has increased the availability and accessibility of these medications[2].

Challenges and Pitfalls

Competition from Generic and Branded Products

• The market faces competition from both generic and branded products. For example, Dermavant’s Vtama, a nonsteroidal topical treatment, has struggled to gain traction despite its potential, due to competition from generic topical steroids and other branded products[5].

Perception and Coverage Issues

• Prescribers and patients often face issues related to coverage, especially at larger pharmacies. This can create a perception gap that hampers the growth of new products in the market[5].

Sales Projections and Market Trends

Current Market Performance

• The global topical corticosteroids market is expected to grow steadily, with a projected value of USD 8.19 billion by 2030. This growth is supported by the increasing demand for effective topical treatments for skin conditions[2].

Regional Growth Projections

• The Asia Pacific region is expected to register the fastest CAGR during the forecast period, driven by factors such as rising healthcare expenditures and a higher prevalence of skin disorders[4].

Impact of New Approvals and Indications

• New approvals and indications for existing products can significantly impact sales projections. For instance, the potential approval of Vtama for atopic dermatitis could open up a larger market, particularly among children, where non-steroidal and non-systemic drugs are preferred[5].

Key Players in the Topical Drugs CDMO Market

• Prominent players in the topical drugs CDMO market include Lubrizol Life Science, Cambrex Corporation, Contract Pharmaceuticals Limited, Bora Pharmaceutical CDMO, Ascendia Pharmaceuticals, and the Pierre Fabre group. These companies are driving market growth through strategic initiatives, extensive product portfolios, and advanced treatment options for skin diseases[1][3].

Market Segmentation

By Product Type

• The semi-solid formulations segment accounted for the largest revenue share in the topical drugs CDMO market, primarily due to the increasing approval of semi-solid topical drugs in recent years[1].

By Therapeutic Area

• The market is segmented by therapeutic areas such as skin conditions, chronic diseases, and others. The rising prevalence of skin conditions globally is a significant driver for this segment[4].

By Service Type

• The market is also segmented by service type, including manufacturing, formulation development, and packaging. The demand for these services is increasing due to the growing need for outsourced pharmaceutical services[3].

Conclusion

The topical corticosteroids market, including products like those under the generic name Topirol, is poised for significant growth driven by increasing demand for effective topical treatments, advancements in medical research, and regulatory approvals. However, the market faces challenges such as competition from generic and branded products and perception issues related to coverage.

Key Takeaways

• The global topical corticosteroids market is projected to reach USD 8.19 billion by 2030.
• North America is the largest market, but the Asia Pacific region is expected to grow the fastest.
• Increasing prevalence of skin conditions and advancements in medical research are key drivers.
• Competition from generic and branded products and coverage issues are significant challenges.
• New approvals and indications can significantly impact sales projections.

FAQs

What is the current size of the global topical corticosteroids market?

The global Topical Corticosteroids Market was valued at USD 4.85 billion in 2021[2].

What is the projected growth rate of the global topical corticosteroids market?

The market is growing at a CAGR of 6% from 2021 to 2030[2].

Which region dominates the topical corticosteroids market?

North America emerged as the largest market for topical corticosteroids in 2021, with a market share of around 38%[2].

What are the key drivers of the topical corticosteroids market?

Key drivers include the increasing prevalence of skin conditions, advancements in medical research, and regulatory approvals[2][4].

What challenges does the topical corticosteroids market face?

The market faces challenges such as competition from generic and branded products and perception issues related to coverage[5].

How does the Asia Pacific region contribute to the growth of the topical corticosteroids market?

The Asia Pacific region is expected to grow the fastest during the forecast period, driven by rising healthcare expenditures, higher prevalence of skin disorders, and enhanced awareness of dermatological health[2][4].

Sources

1. Grandview Research: Topical Drugs CDMO Market Size And Share Report, 2030
2. Spherical Insights: Topical Corticosteroids Market Size, Analysis, Forecasts to 2030
3. GMI Insights: Topical Drugs CDMO Market Size & Share Report, 2024 – 2032
4. Grandview Research: Topical Drugs Market Size And Share | Industry Report, 2030
5. Fierce Pharma: Stagnant sales for Dermavant's Vtama cast doubt on its blockbuster potential